- Home
- VITL vs HRMY Comparison
VITL vs HRMY Comparison
Compare VITL & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VITL
- HRMY
- Stock Information
- Founded
- VITL 2007
- HRMY 2017
- Country
- VITL United States
- HRMY United States
- Employees
- VITL N/A
- HRMY N/A
- Industry
- VITL Packaged Foods
- HRMY Biotechnology: Pharmaceutical Preparations
- Sector
- VITL Consumer Staples
- HRMY Health Care
- Exchange
- VITL Nasdaq
- HRMY Nasdaq
- Market Cap
- VITL 1.5B
- HRMY 2.0B
- IPO Year
- VITL 2020
- HRMY 2020
- Fundamental
- Price
- VITL $31.91
- HRMY $34.50
- Analyst Decision
- VITL Strong Buy
- HRMY Strong Buy
- Analyst Count
- VITL 8
- HRMY 8
- Target Price
- VITL $43.88
- HRMY $53.38
- AVG Volume (30 Days)
- VITL 809.4K
- HRMY 751.0K
- Earning Date
- VITL 05-08-2025
- HRMY 05-06-2025
- Dividend Yield
- VITL N/A
- HRMY N/A
- EPS Growth
- VITL 30.46
- HRMY 13.13
- EPS
- VITL 1.13
- HRMY 2.62
- Revenue
- VITL $620,567,000.00
- HRMY $744,852,000.00
- Revenue This Year
- VITL $25.26
- HRMY $20.35
- Revenue Next Year
- VITL $19.41
- HRMY $17.42
- P/E Ratio
- VITL $28.29
- HRMY $13.16
- Revenue Growth
- VITL 23.96
- HRMY 20.62
- 52 Week Low
- VITL $27.91
- HRMY $26.47
- 52 Week High
- VITL $48.41
- HRMY $41.61
- Technical
- Relative Strength Index (RSI)
- VITL 41.85
- HRMY 58.40
- Support Level
- VITL $31.40
- HRMY $33.47
- Resistance Level
- VITL $36.28
- HRMY $35.35
- Average True Range (ATR)
- VITL 1.16
- HRMY 1.13
- MACD
- VITL -0.38
- HRMY -0.10
- Stochastic Oscillator
- VITL 17.42
- HRMY 42.41
About VITL Vital Farms Inc.
Vital Farms Inc is an ethical food company. The company retails pasture-raised eggs and butter. Its products include Pasture-Raised Eggs and Pasture-Raised Butter & Ghee. The company's purpose is rooted in a commitment to Conscious Capitalism, which prioritizes the long-term benefits of its stakeholders (farmers and suppliers, customers and consumers, communities and the environment, employees, and stockholders).
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.